Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianping Weng

Showing results (91-100 of 295) with videos related to

Pageof 30
Sort By:
The Journal of Endocrinology|May 29, 2019
Exenatide mitigates inflammation and hypoxia along with improved angiogenesis in obese fat tissueYingxin Xian, Zonglan Chen, Hongrong Deng, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|April 21, 2022
Advances of functional nanomaterials for magnetic resonance imaging and biomedical engineering applicationsRuijie Huang, Xingyu Zhou, Guiyuan Chen, et al.
International Journal of Endocrinology|June 26, 2019
Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling PathwayPeng Yu, Xi Xu, Jing Zhang, et al.
Science China. Life Sciences|June 15, 2019
Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetesXubin Yang, Hongrong Deng, Xiuzhen Zhang, et al.
Journal of Diabetes|May 10, 2014
China type 2 diabetes treatment status survey of treatment pattern of oral drugs usersLinong Ji, Juming Lu, Jianping Weng, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|August 20, 2015
GLP-1 Receptor Agonist Exenatide Attenuates the Detrimental Effects of Obesity on Inflammatory Profile in Testis and Sperm Quality in MiceErhong Zhang, Fen Xu, Hua Liang, et al.
Diabetes/Metabolism Research and Reviews|September 9, 2014
Short-term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gapsJianping Weng, Ravi Retnakaran, Ammini Ariachery C, et al.
Experimental Neurology|April 22, 2010
Statins: multiple neuroprotective mechanisms in neurodegenerative diseasesQing Wang, Junqiang Yan, Xiaohong Chen, et al.
Biochemical and Biophysical Research Communications|July 22, 2022
A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db miceMengyun Xu, Xiumei Wu, Zhenghong Liu, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|June 20, 2020
Nanotechnology's application in Type 1 diabetesWen Pan, Xueying Zheng, Guiyuan Chen, et al.
Pageof 30

Showing results (91-100 of 295) with videos related to

Sort By:
Pageof 30
The Journal of Endocrinology|May 29, 2019
Exenatide mitigates inflammation and hypoxia along with improved angiogenesis in obese fat tissueYingxin Xian, Zonglan Chen, Hongrong Deng, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|April 21, 2022
Advances of functional nanomaterials for magnetic resonance imaging and biomedical engineering applicationsRuijie Huang, Xingyu Zhou, Guiyuan Chen, et al.
International Journal of Endocrinology|June 26, 2019
Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling PathwayPeng Yu, Xi Xu, Jing Zhang, et al.
Science China. Life Sciences|June 15, 2019
Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetesXubin Yang, Hongrong Deng, Xiuzhen Zhang, et al.
Journal of Diabetes|May 10, 2014
China type 2 diabetes treatment status survey of treatment pattern of oral drugs usersLinong Ji, Juming Lu, Jianping Weng, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|August 20, 2015
GLP-1 Receptor Agonist Exenatide Attenuates the Detrimental Effects of Obesity on Inflammatory Profile in Testis and Sperm Quality in MiceErhong Zhang, Fen Xu, Hua Liang, et al.
Diabetes/Metabolism Research and Reviews|September 9, 2014
Short-term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gapsJianping Weng, Ravi Retnakaran, Ammini Ariachery C, et al.
Experimental Neurology|April 22, 2010
Statins: multiple neuroprotective mechanisms in neurodegenerative diseasesQing Wang, Junqiang Yan, Xiaohong Chen, et al.
Biochemical and Biophysical Research Communications|July 22, 2022
A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db miceMengyun Xu, Xiumei Wu, Zhenghong Liu, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|June 20, 2020
Nanotechnology's application in Type 1 diabetesWen Pan, Xueying Zheng, Guiyuan Chen, et al.
Pageof 30